New radiation target method for high-grade glioma
Part of Cancer, Injuries & trauma clinical trials.
This study is testing a new way to target radiation for people with high-grade gliomas (aggressive brain tumors). The goal is to see if a more precise treatment plan can improve outcomes while keeping side effects low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a high-grade glioma (brain tumor) that is WHO grade 3 or 4.
- You are between 18 and 65 years old and able to do most daily activities on your own (KPS score 70 or higher).
- You had brain surgery to remove the tumor without any serious complications.
- You can start radiation therapy 4 to 6 weeks after surgery and take the chemotherapy drug temozolomide safely.
- You do not have other active cancers, serious health conditions, or are pregnant/breastfeeding.
- You are willing to provide tissue and blood samples for research and return for follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation therapy for glioblastoma (a type of brain cancer) using a machine that combines MRI imaging with radiation. The goal is to safely intensify the treatment and improve outcomes.
This study tests a combination of three treatments for newly diagnosed high-grade glioma: a drug called ADI-PEG 20, chemotherapy (temozolomide), and radiation therapy. The goal is to see if this combination is safe and effective for children and young adults with this type of brain or spinal cord tumor.
This trial tests a new oral drug called XRD-0394 given together with radiation therapy for people with high-grade glioma, a type of aggressive brain tumor. The goal is to see if adding this drug makes radiation more effective.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This early-phase study tests a type of very targeted radiation given before surgery for people with a high-grade (aggressive) brain tumor. The goal is to see if this approach is safe and potentially improves treatment, while collecting tumor and blood samples for research.
This trial tests a new type of targeted radiation therapy for people with high-grade glioma (grade 3 or 4) that has not progressed after standard treatment. The therapy uses a radioactive substance attached to a protein that targets tumor cells, aiming to deliver radiation directly to the cancer.
Hear when a new Radiation Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.